Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1384 |
Resumo: | Introduction: The National Health Surveillance Agency (Anvisa) defines cosmetovigilance as the set of measures that allows assessing the risk of occurrence of undesirable events attributed to the use of cosmetic products, including the capture of adverse events (AE). From 2006 Anvisa began to receive EA notifications involving cosmetic products, with the implementation of the Sanitary Surveillance Notification System (Notivisa). Objective: This study analyzed the notifications of adverse effects related to the use of cosmetic products, registered in Notivisa, from 2006 to 2018. Method: This is a quantitative, descriptive and retrospective study whose database was extracted from the Notivisa system, nationwide, from November 2006 to December 2018. Results: We identified 367 adverse effects involving cosmetic products with an average of 31 notifications per year. Reports of adverse effects came mainly from the Southeast (48.1%; 176) and South (25.1%; 92) regions of the country with a predominance of females (66.2%; 243). It was observed that the citizen is the on ewho most reports adverse effects (58.0%; 213) related to cosmetic products, with more complaints about infant and geriatric diapers (15.0%; 26), facial / body creams (14.1%; 24), hair straighteners (17.8%; 35) and sunscreens (14.8%; 29). The most common adverse effects were irritation (46.0%; 17), allergy (30.5%; 11) and burning (30.5%; 11). The reported effects are mostly performed by female citizens from the richest regions of the country, attributed to products of daily use and characterized by the presence of irritation, allergy and burning. Conclusions: These results have demonstrated the need to improve Anvisa’s Cosmetovigilance System, defining strategies for adherence to adverse effect reports, as well as the adoption of a causal assessment method appropriate to the specificities of cosmetic products. |
id |
FIOCRUZ-9_d0f70afec1fb4ffbdbcc303fc7eac749 |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/1384 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018Análise descritiva das notificações de eventos adversos de produtos cosméticos registradas no Notivisa, no período de 2006 a 2018Brazilian Health Surveillance AgencyBrazilCosmeticsAdverse EffectHealth SurveillanceCosmetovigilanceAgência Nacional de Vigilância SanitáriaBrasilCosméticosEfeitos AdversosVigilância SanitáriaCosmetovigilânciaIntroduction: The National Health Surveillance Agency (Anvisa) defines cosmetovigilance as the set of measures that allows assessing the risk of occurrence of undesirable events attributed to the use of cosmetic products, including the capture of adverse events (AE). From 2006 Anvisa began to receive EA notifications involving cosmetic products, with the implementation of the Sanitary Surveillance Notification System (Notivisa). Objective: This study analyzed the notifications of adverse effects related to the use of cosmetic products, registered in Notivisa, from 2006 to 2018. Method: This is a quantitative, descriptive and retrospective study whose database was extracted from the Notivisa system, nationwide, from November 2006 to December 2018. Results: We identified 367 adverse effects involving cosmetic products with an average of 31 notifications per year. Reports of adverse effects came mainly from the Southeast (48.1%; 176) and South (25.1%; 92) regions of the country with a predominance of females (66.2%; 243). It was observed that the citizen is the on ewho most reports adverse effects (58.0%; 213) related to cosmetic products, with more complaints about infant and geriatric diapers (15.0%; 26), facial / body creams (14.1%; 24), hair straighteners (17.8%; 35) and sunscreens (14.8%; 29). The most common adverse effects were irritation (46.0%; 17), allergy (30.5%; 11) and burning (30.5%; 11). The reported effects are mostly performed by female citizens from the richest regions of the country, attributed to products of daily use and characterized by the presence of irritation, allergy and burning. Conclusions: These results have demonstrated the need to improve Anvisa’s Cosmetovigilance System, defining strategies for adherence to adverse effect reports, as well as the adoption of a causal assessment method appropriate to the specificities of cosmetic products.Introdução: A Agência Nacional de Vigilância Sanitária (Anvisa) define a cosmetovigilância como o conjunto de medidas que permite avaliar o risco de ocorrência de eventos indesejáveis atribuídos à utilização de produtos cosméticos, contemplando a captação dos eventos adversos (EA). A partir do ano de 2006 a Anvisa passou a receber as notificações de EA envolvendo produtos cosméticos, com a implementação do Sistema de Notificação para a Vigilância Sanitária (Notivisa). Objetivo: Este estudo analisou as notificações dos EA relacionados ao uso de produtos cosméticos, registradas no Notivisa, no período de 2006 a 2018. Método: Trata-se de um estudo quantitativo, descritivo e retrospectivo, cujo banco de dados foi extraído do sistema Notivisa, em âmbito nacional, no período de novembro de 2006 até dezembro de 2018. Resultados: Foram identificados 367 EA envolvendo produtos cosméticos com uma média de 31 notificações por ano. Os relatos dos EA foram provenientes, principalmente, das regiões Sudeste (48,1%; 176) e Sul (25,1%; 92) do país, com predominância do sexo feminino (66,2%; 243). Observou-se que o cidadão é quem mais notifica EA (58,0%; 213) relacionados a produtos cosméticos, com maior queixa sobre: fraldas infantis e geriátricas (15,0%; 26), cremes facial/corporal (14,1%; 24), alisantes capilares (17,8%; 35) e protetores solares (14,8%; 29). Os EA mais frequentes foram: irritação (46,0%; 17), alergia (30,5%; 11) e ardor (30,5%; 11). Os eventos relatados são, em sua maioria, realizados por cidadãos do sexo feminino e oriundos das regiões mais ricas do país, atribuídos a produtos de uso diário e caracterizados pela presença de irritação, alergia e ardor. Conclusões: Tais resultados demonstraram a necessidade de aperfeiçoamento do Sistema de Cosmetovigilância da Anvisa, com definição de estratégias para adesão às notificações de EA, bem como, a adoção de um método de avaliação de causalidade adequado às especificidades de produtos cosméticos.Instituto Nacional de Controle de Qualidade em Saúde2019-11-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/138410.22239/2317-269X.01384Health Surveillance under Debate: Society, Science & Technology ; Vol. 7 No. 4 (2019): November - Rede Sentinela; 17-25Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 7 Núm. 4 (2019): Noviembre - Rede Sentinela; 17-25Vigil Sanit Debate, Rio de Janeiro; v. 7 n. 4 (2019): Novembro - Rede Sentinela; 17-252317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1384/1094https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1384/1174Copyright (c) 2019 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessPenna Teixeira, Ana Paula Coelhode Almeida, Andreia CarlaMelo, Danilo FeitozaLeitão, Leonardo OliveiraSilva, Luis Henrique Calazans2023-06-27T15:11:58Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1384Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:11:58Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 Análise descritiva das notificações de eventos adversos de produtos cosméticos registradas no Notivisa, no período de 2006 a 2018 |
title |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 |
spellingShingle |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 Penna Teixeira, Ana Paula Coelho Brazilian Health Surveillance Agency Brazil Cosmetics Adverse Effect Health Surveillance Cosmetovigilance Agência Nacional de Vigilância Sanitária Brasil Cosméticos Efeitos Adversos Vigilância Sanitária Cosmetovigilância |
title_short |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 |
title_full |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 |
title_fullStr |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 |
title_full_unstemmed |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 |
title_sort |
Descriptive analysis of notifications of adverse events of cosmetic products registered in Notivisa, from 2006 to 2018 |
author |
Penna Teixeira, Ana Paula Coelho |
author_facet |
Penna Teixeira, Ana Paula Coelho de Almeida, Andreia Carla Melo, Danilo Feitoza Leitão, Leonardo Oliveira Silva, Luis Henrique Calazans |
author_role |
author |
author2 |
de Almeida, Andreia Carla Melo, Danilo Feitoza Leitão, Leonardo Oliveira Silva, Luis Henrique Calazans |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Penna Teixeira, Ana Paula Coelho de Almeida, Andreia Carla Melo, Danilo Feitoza Leitão, Leonardo Oliveira Silva, Luis Henrique Calazans |
dc.subject.por.fl_str_mv |
Brazilian Health Surveillance Agency Brazil Cosmetics Adverse Effect Health Surveillance Cosmetovigilance Agência Nacional de Vigilância Sanitária Brasil Cosméticos Efeitos Adversos Vigilância Sanitária Cosmetovigilância |
topic |
Brazilian Health Surveillance Agency Brazil Cosmetics Adverse Effect Health Surveillance Cosmetovigilance Agência Nacional de Vigilância Sanitária Brasil Cosméticos Efeitos Adversos Vigilância Sanitária Cosmetovigilância |
description |
Introduction: The National Health Surveillance Agency (Anvisa) defines cosmetovigilance as the set of measures that allows assessing the risk of occurrence of undesirable events attributed to the use of cosmetic products, including the capture of adverse events (AE). From 2006 Anvisa began to receive EA notifications involving cosmetic products, with the implementation of the Sanitary Surveillance Notification System (Notivisa). Objective: This study analyzed the notifications of adverse effects related to the use of cosmetic products, registered in Notivisa, from 2006 to 2018. Method: This is a quantitative, descriptive and retrospective study whose database was extracted from the Notivisa system, nationwide, from November 2006 to December 2018. Results: We identified 367 adverse effects involving cosmetic products with an average of 31 notifications per year. Reports of adverse effects came mainly from the Southeast (48.1%; 176) and South (25.1%; 92) regions of the country with a predominance of females (66.2%; 243). It was observed that the citizen is the on ewho most reports adverse effects (58.0%; 213) related to cosmetic products, with more complaints about infant and geriatric diapers (15.0%; 26), facial / body creams (14.1%; 24), hair straighteners (17.8%; 35) and sunscreens (14.8%; 29). The most common adverse effects were irritation (46.0%; 17), allergy (30.5%; 11) and burning (30.5%; 11). The reported effects are mostly performed by female citizens from the richest regions of the country, attributed to products of daily use and characterized by the presence of irritation, allergy and burning. Conclusions: These results have demonstrated the need to improve Anvisa’s Cosmetovigilance System, defining strategies for adherence to adverse effect reports, as well as the adoption of a causal assessment method appropriate to the specificities of cosmetic products. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-11-26 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1384 10.22239/2317-269X.01384 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1384 |
identifier_str_mv |
10.22239/2317-269X.01384 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1384/1094 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1384/1174 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 7 No. 4 (2019): November - Rede Sentinela; 17-25 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 7 Núm. 4 (2019): Noviembre - Rede Sentinela; 17-25 Vigil Sanit Debate, Rio de Janeiro; v. 7 n. 4 (2019): Novembro - Rede Sentinela; 17-25 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042045459628032 |